SHANGHAI, CHINA--(Marketwire - July 30, 2008) - Sinobiomed Inc. (“Sinobiomed”, or “the Company”) (OTCBB: SOBM) is pleased to announce that it has secured a portion of US$500,000 in new convertible debenture funding that an Asian-based investment fund, Accelera Ventures Ltd., has committed to invest in the Company.
